# EDGAR Filing Document

**Accession Number:** 0001472072
**File Stem:** 0001104659-26-030216
**Filing Date:** 2026-3
**Character Count:** 9055
**Document Hash:** b4e71f0afed5087944bd8dd9f021fd00
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-26-030216.hdr.sgml**: 20260318

**ACCESSION NUMBER**: 0001104659-26-030216

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20260318

**FILED AS OF DATE**: 20260318

**DATE AS OF CHANGE**: 20260318

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Yang Jianyu
- **CENTRAL INDEX KEY:** 0002119873

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-34563
- **FILM NUMBER:** 26766696

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** ROOM A1-A5 26/F, EAST ZONE, HANWEI PLAZA
- **STREET 2:** NO. 7 GUANGHUA ROAD, CHAOYANG DISTRICT
- **CITY:** BEIJING
- **PROVINCE COUNTRY:** F4
- **ZIP:** 100020
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Concord Medical Services Holdings Ltd
- **CENTRAL INDEX KEY:** 0001472072
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** E9

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** ROOM 26A1-26A5, EAST TOWER, HANWEI
- **STREET 2:** BUILDING NO. 7 GUANGHUA ROAD
- **CITY:** CHAOYANG DISTRICT, BEIJING
- **PROVINCE COUNTRY:** F4
- **ZIP:** 100020
- **BUSINESS PHONE:** (86)10-5825-6867

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** ROOM 26A1-26A5, EAST TOWER, HANWEI
- **STREET 2:** BUILDING NO. 7 GUANGHUA ROAD
- **CITY:** CHAOYANG DISTRICT, BEIJING
- **PROVINCE COUNTRY:** F4
- **ZIP:** 100020

## Ex-24

**Exhibit 24**

**SECTION 16<br> POWER OF ATTORNEY**

With respect to holdings of and transactions in securities issued by Concord Medical Services Holdings Limited (the "***Company***"), the undersigned hereby constitutes and appoints the Chief Financial Officer of the Company, who is currently Wei Jiang, and his respective successors, as may be amended from time to time, signing singly, with full power of substitution and resubstitution, to act as the undersigned's true and lawful attorney-in-fact to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. execute for and on behalf of the undersigned, Forms 3, 4, and 5 (including amendments thereto) in accordance
with Section 16 of the Securities Exchange Act of 1934, as amended (the "  ***Exchange Act*** "), and the rules thereunder;
and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable
to complete and execute any such Forms 3, 4 or 5, complete and execute any amendment or amendments thereto, and timely file such forms
(including amendments thereto) with the United States Securities and Exchange Commission and any stock exchange or similar authority.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution and resubstitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorneys-in-fact substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted.

The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file any Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier (a) revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact or (b) superseded by a new power of attorney regarding the purposes outlined in the first paragraph hereof dated as of a later date.

[*Signature page follows*]

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 18th day of March, 2026.

---

| |
|:---|
| /s/ Jianyu Yang |
| **Jianyu Yang** |

---

[Signature Page to Power of Attorney]

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Yang Jianyu<br><sub>(Last) (First) (Middle)</sub><br>SEE REMARKS<br><sub>(Street)</sub><br>BEIJING, CHINA 100020<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>Concord Medical Services Holdings Ltd [ CCM ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2026-03-18 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_Chief Executive Officer_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| American depositary shares | 466097 | I | By Morgancreek Investment Holding Limited<sup>(1)(4)</sup> |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Class B ordinary shares, par value US$0.0001 per share | <sup>(3)</sup> | <sup>(3)</sup> | Class A ordinary shares, par value US$0.0001 per share | 38287948 | <sup>(3)</sup> | I | By Morgancreek Investment Holding Limited<sup>(2)(4)</sup> |

---

### Footnotes:

(1) Represented 466,097 American depositary shares ("ADSs"), each representing 30 Class A ordinary shares, par value US$0.0001 per share, of the Issuer (the "Class A Ordinary Shares") held by Morgancreek Investment Holding Limited ("Morgancreek"), a limited liability company organized under the laws of the British Virgin Islands.

(2) Represented 38,287,948 Class B ordinary shares, par value US$0.0001 per share, of the Issuer ("Class B Ordinary Shares), held by Morgancreek.

(3) The Class B Ordinary Shares are convertible at any time at the option of the holder into an equal number of Class A Ordinary Shares at no cost.

(4) The Reporting Person is the sole director of Morgancreek and the Reporting Person's spouse indirectly holds 70% of the equity interests in Morgancreek. As such the Reporting Person has the power to direct Morgancreek as to the voting and disposition of the Class B Ordinary Shares and the ADSs held by Morgancreek. The Reporting Person may be deemed the beneficial owner of all the Class B Ordinary Shares and ADSs representing Class A Ordinary Shares held by Morgancreek.

**Remarks:**
The full street address is Room A1-A5 26/F, East Zone, Hanwei Plaza, No. 7 Guanghua Road, Chaoyang District. Exhibit 24 - Power of Attorney

**Signature:** /s/ Jianyu Yang  
**Date:** 2026-03-18

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**